This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Futures are trading lower on Wednesday after an ADP ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...

Investing.com - Citizens JMP has reiterated its Market Outperform rating and $38.00 price target on Acadia Pharmaceuticals (NASDAQ:ACAD), currently trading at $24.76, as the company prepares to report ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Thomas J Catalano is a CFP and Registered ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min 67-year-old company plans move ...

JMP highlighted the "highly compelling" nature of the results, noting a pooled, placebo-adjusted clinical remission rate of 16.4% with statistical significance (p The research firm increased its ...

Life is uncertain. None of us know what is going to happen. We know little of what has happened in the past or is happening now outside our immediate experience. Uncertainty has been called the ...

The analyst firm projects that obefazimod could achieve peak global sales of approximately $2.5 billion in ulcerative colitis treatment, assigning a 60% probability of approval for this indication.